Cargando…
Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
Sulindac is an FDA-approved non-steroidal anti-inflammatory drug with documented anticancer activities. Our recent studies showed that sulindac selectively enhanced the killing of cancer cells exposed to oxidizing agents via production of reactive oxygen species (ROS) resulting in mitochondrial dysf...
Autores principales: | Ayyanathan, Kasirajan, Kesaraju, Shailaja, Dawson-Scully, Ken, Weissbach, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398923/ https://www.ncbi.nlm.nih.gov/pubmed/22866174 http://dx.doi.org/10.1371/journal.pone.0039949 |
Ejemplares similares
-
Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
por: Marchetti, Maria, et al.
Publicado: (2009) -
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023) -
Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation
por: Torabizadeh, Seyedeh Atekeh, et al.
Publicado: (2019) -
Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018) -
Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)